ArticleMolecular cancer research : MCR2023

Metabolic Imaging as a Tool to Characterize Chemoresistance and Guide Therapy in Triple-Negative Breast Cancer (TNBC).

Enakshi D Sunassee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.